Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration
Clinical trial NCT03777254 · COMPLETED
Trial details
- NCT number
- NCT03777254
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2019-08-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.